These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 11324695

  • 1. Role of costimulatory molecules in autoimmunity.
    Kobata T, Azuma M, Yagita H, Okumura K.
    Rev Immunogenet; 2000; 2(1):74-80. PubMed ID: 11324695
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
    Allen SD, Rawale SV, Whitacre CC, Kaumaya PT.
    J Pept Res; 2005 Jun; 65(6):591-604. PubMed ID: 15885118
    [Abstract] [Full Text] [Related]

  • 3. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
    Biburger M, Weth R, Wels WS.
    J Mol Biol; 2005 Mar 11; 346(5):1299-311. PubMed ID: 15713482
    [Abstract] [Full Text] [Related]

  • 4. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K, Neena K, Chitralekha KT, Arif AK, Tomar D, Rao DN.
    Int Immunopharmacol; 2004 Jan 11; 4(1):1-14. PubMed ID: 14975355
    [Abstract] [Full Text] [Related]

  • 5. [Manipulation of costimulatory pathways in autoimmune disease].
    Kaneko H, Nakajima A, Azuma M.
    Nihon Rinsho; 1997 Jun 11; 55(6):1531-6. PubMed ID: 9200944
    [Abstract] [Full Text] [Related]

  • 6. Cross-species costimulation: relative contributions of CD80, CD86, and CD40.
    Rogers NJ, Jackson IM, Jordan WJ, Hawadle MA, Dorling A, Lechler RI.
    Transplantation; 2003 Jun 27; 75(12):2068-76. PubMed ID: 12829914
    [Abstract] [Full Text] [Related]

  • 7. Evidence for the involvement of T cell costimulation through the B-7/CD28 pathway in atherosclerotic plaques from apolipoprotein E knockout mice.
    Afek A, Harats D, Roth A, Keren G, George J.
    Exp Mol Pathol; 2004 Jun 27; 76(3):219-23. PubMed ID: 15126104
    [Abstract] [Full Text] [Related]

  • 8. Functional roles for T cell CD40 in infection and autoimmune disease: the role of CD40 in lymphocyte homeostasis.
    Munroe ME.
    Semin Immunol; 2009 Oct 27; 21(5):283-8. PubMed ID: 19539498
    [Abstract] [Full Text] [Related]

  • 9. Altered expression of the costimulatory molecules CD80, CD86, CD152, PD-1 and ICOS on T-cells from paracoccidioidomycosis patients: lack of correlation with T-cell hyporesponsiveness.
    Cacere CR, Mendes-Giannini MJ, Fontes CJ, Kono A, Duarte AJ, Benard G.
    Clin Immunol; 2008 Nov 27; 129(2):341-9. PubMed ID: 18757242
    [Abstract] [Full Text] [Related]

  • 10. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
    Wong CK, Lit LC, Tam LS, Li EK, Lam CW.
    Rheumatology (Oxford); 2005 Aug 27; 44(8):989-94. PubMed ID: 15870153
    [Abstract] [Full Text] [Related]

  • 11. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
    Ruybal P, Gravisaco MJ, Barcala V, Escalada A, Di Sciullo P, Waldner C, Mongini C.
    Vaccine; 2008 Jan 30; 26(5):697-705. PubMed ID: 18155328
    [Abstract] [Full Text] [Related]

  • 12. Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.
    Chitnis T, Khoury SJ.
    J Allergy Clin Immunol; 2003 Nov 30; 112(5):837-49; quiz 850. PubMed ID: 14610467
    [Abstract] [Full Text] [Related]

  • 13. Targeting lymphocyte co-stimulation: from bench to bedside.
    Felix NJ, Suri A, Salter-Cid L, Nadler SG, Gujrathi S, Corbo M, Aranda R.
    Autoimmunity; 2010 Nov 30; 43(7):514-25. PubMed ID: 20429850
    [Abstract] [Full Text] [Related]

  • 14. Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation.
    Saverino D, Brizzolara R, Simone R, Chiappori A, Milintenda-Floriani F, Pesce G, Bagnasco M.
    Clin Immunol; 2007 May 30; 123(2):190-8. PubMed ID: 17321799
    [Abstract] [Full Text] [Related]

  • 15. Costimulation of memory T-cells by ICOS: a potential therapeutic target for autoimmunity?
    Sporici RA, Perrin PJ.
    Clin Immunol; 2001 Sep 30; 100(3):263-9. PubMed ID: 11513539
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CD40 can costimulate human memory T cells and favors IL-10 secretion.
    Rogers NJ, Jackson IM, Jordan WJ, Lombardi G, Delikouras A, Lechler RI.
    Eur J Immunol; 2003 Apr 30; 33(4):1094-104. PubMed ID: 12672076
    [Abstract] [Full Text] [Related]

  • 19. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J.
    Clin Cancer Res; 2003 May 30; 9(5):1837-49. PubMed ID: 12738742
    [Abstract] [Full Text] [Related]

  • 20. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation.
    Mejri N, Gottstein B.
    Parasite Immunol; 2006 Aug 30; 28(8):373-85. PubMed ID: 16879309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.